Literature DB >> 813912

Antibodies mediating type I skin test reactions to polysaccharide and protein antigens of Candida albicans.

J L Longbottom, W D Brighton, G Edge, J Pepys.   

Abstract

Immediate, type I, prick test reactions in man to purified fractions of Candida albicans group A were mediated by different classes of antibody. The allergens were the cell-wall polysaccharide, mannan, and 'purified' cytoplasmic protein fraction, free of mannan, prepared by passage through Sepharose-concanavalin-A. Passive transfer tests in the monkey gave immediate reactions, (1) to the purified, cytoplasmic, protein mediated by heat-labile long-term sensitizing antibody, and (2) to the polysaccharide, mannan, mediated by heat-stable short-term sensitizing antibody.

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 813912     DOI： 10.1111/j.1365-2222.1976.tb01410.x

Source DB:  PubMed          Journal:  Clin Allergy        ISSN： 0009-9090


  12 in total

Review 1.  Allergens of the fungi imperfecti.

Authors:  R Einarsson; L Aukrust
Journal:  Clin Rev Allergy       Date:  1992

2.  Use of immunoblotting to identify antigenic differences between the yeast and mycelial phases of Candida albicans.

Authors:  J P Burnie; R C Matthews; A Fox; S Tabaqchali
Journal:  J Clin Pathol       Date:  1985-06       Impact factor: 3.411

Review 3.  Nonreaginic anaphylactic antibodies in man.

Authors:  B F Goodwin
Journal:  Clin Rev Allergy       Date:  1983-06

4.  Immunoglobulin A1 and A2 subclass of salivary antibodies to Candida albicans in patients with oral candidosis.

Authors:  S Jeganathan; D Ufomata; J A Hobkirk; L Ivanyi
Journal:  Clin Exp Immunol       Date:  1987-11       Impact factor: 4.330

5.  Identification of Candida albicans antigens reactive with immunoglobulin E antibody of human sera.

Authors:  A Ishiguro; M Homma; S Torii; K Tanaka
Journal:  Infect Immun       Date:  1992-04       Impact factor: 3.441

6.  Specific inhibition of in vitro Candida-induced lymphocyte proliferation by polysaccharidic antigens present in the serum of patients with chronic mucocutaneous candidiasis.

Authors:  A Fischer; J J Ballet; C Griscelli
Journal:  J Clin Invest       Date:  1978-11       Impact factor: 14.808

7.  Immunological investigations of Candida albicans in respiratory disease.

Authors:  G Edge; J L Longbottom; R D Tee; J Pepys
Journal:  Br J Clin Pharmacol       Date:  1977       Impact factor: 4.335

8.  Antigens/allergens of Aspergillus fumigatus. Identification of antigenic components reacting with both IgG and IgE antibodies of patients with allergic bronchopulmonary aspergillosis.

Authors:  J L Longbottom
Journal:  Clin Exp Immunol       Date:  1983-08       Impact factor: 4.330

9.  Purification and characterization of a major cytoplasmic antigen of Candida albicans.

Authors:  R A Greenfield; J M Jones
Journal:  Infect Immun       Date:  1981-11       Impact factor: 3.441

10.  Purification of cytoplasmic antigens from the mycelial phase of Candida albicans: possible advantages of its use in Candida serology.

Authors:  M Munoz; G Estes; M Kilpatrick; A Di Salvo; G Virella
Journal:  Mycopathologia       Date:  1980-08-29       Impact factor: 2.574
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.